Fri, Aug 29, 2014, 1:21 AM EDT - U.S. Markets open in 8 hrs 9 mins

Recent

% | $
Quotes you view appear here for quick access.

Optimer Pharmaceuticals, Inc. (OPTR) Message Board

  • superbowlchampstealers2006 superbowlchampstealers2006 Jun 28, 2011 2:17 PM Flag

    Cubist Pharmaceuticals could provide potential for acquirer down the road

    Optimer Pharmaceuticals (OPTR)
    The FDA recently approved their clostridium difficile associated diarrhea (CDAD) drug received FDA drug approval. This company is interesting because of the growing occurrences of this disease in adults and individuals in long-term care facilities. This could imply a secular growth opportunity. The stock rallied following the positive FDA news but has since slumped. For bullish investors, this may be a longer term buying opportunity.

    Their partnership with Cubist Pharmaceuticals could provide potential for acquirer down the road.

 
OPTR
12.780.00(0.00%)Oct 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.